The pharmaceutical and biological sector has been heavily sold off by the main funds in the past three days

Clinical CRO Tigermed: The ‘Small and Beautiful’

In this race of pharmaceutical R&D outsourcing segment, WuXi AppTec, Pharmaron, Tigermed and Asychem are some of the major names – but which has a truly winning side?

Taobao Takes Double 11 to 20 Overseas Markets, Adding Free Shipping and More Than 1.2 Million Merchants

Taobao plans to run this year’s Double 11 shopping festival across 20 overseas markets, with free-shipping offers in 13 countries and regions and more than 1.2 million Taobao and Tmall merchants participating, the company said on September 21. The campaign extends the platform’s international push beyond small parcels, with furniture and home-improvement goods among the medium and large items it aims to ship directly overseas.

CRO ClinChoice Raises USD 150 Mn in Series E Round

2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.

CRO Giant Tigermed’s 1H 2020 Net Profits Up 98%

Chinese CRO industry is setting off – the continued pandemic may bring the most potential to this industry.

WuXi AppTec: A Favorable Chinese Stock for MSCI and FTSE Russell

According to the latest quarterly index review, a Wuxi-based CRO company will be incorporated into the FTSE China A 50 Share Index.  It has been considered a top holding by many MSCI China indexes for some time.